Contact
News
Stock Info
Governance
Financials & Filings
Resources

*

Stock

Stock info

icon

Upcoming Events

Show all

GE HealthCare Third Quarter 2026 Earnings Conference Call

Earnings Webcast

GE HealthCare Second Quarter 2026 Earnings Conference Call

Earnings Webcast
Earnings Release 933.5 KB
Earnings Presentation 740.8 KB
Earnings Supplemental 103.1 KB

Hear from CEO Peter Arduini

Upcoming Events

October 28, 2026 at 8:30 AM EDT
GE HealthCare Third Quarter 2026 Earnings Conference Call
Add to Outlook
Add to Google Calendar
Listen to webcast

View all events

Presentations

44th Annual J.P. Morgan Healthcare Conference – January 13, 2026

GE HealthCare Investor Day – November 21, 2024

GE HealthCare Investor Day – November 21, 2024

GE HealthCare’s 2025 Sustainability Report

Sustainability 2025

>$1.7bn

innovation investment*

1bn

patients served annually

~5m

units installed across the globe

$20.6bn

revenue in 2025

*Includes Research and development expense plus engineering costs for design follow-through on new product introductions and key product lifecycle maintenance subsequent to the initial product launch reported within cost of revenues

News & events

Stay up to date with GE HealthCare's latest investor news and events

October 15, 2026

GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68

News Release arrow-icon

October 7, 2026

GE HealthCare to announce third quarter 2026 results on October 28, 2026

News Release arrow-icon

October 5, 2026

GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.

News Release arrow-icon

October 28, 2026 at 8:30 AM EDT
GE HealthCare Third Quarter 2026 Earnings Conference Call
Add to Outlook
Add to Google Calendar
Listen to webcast
September 9, 2026 at 10:15 AM EDT
Wells Fargo 21st Annual Health Conference
Listen to webcast
July 29, 2026 at 8:30 AM EDT
GE HealthCare Second Quarter 2026 Earnings Conference Call
Listen to webcast
More information is coming soon.

A message from Chief Commercial and Growth Officer, Global Markets

Catherine Estrampes
quote-icon

As demand for radiopharmaceuticals continues to grow, we are seeing strong momentum across our portfolio, including our disease-specific tracer that support greater diagnostic confidence. Catholic Health is one example of a health system we’re collaborating with to advance precision care, beginning with its early adoption of Flyrcado and expanding through a recent Care Alliance that includes investments in PET/CT and nuclear medicine capabilities. Together, these efforts reflect the growing demand for precision diagnostics and advanced technologies that help bring innovative care closer to patients.” 
Catherine Estrampes, Chief Commercial and Growth Officer, Global Markets, GE HealthCare

Quick Links

SEC Filings

FAQs

Contacts

Institutional and fixed income investors

Carolynne Borders, Investor relations

carolynne.borders@gehealthcare.com

Attn: Investor relations

GE HealthCare

500 West Monroe Street

Chicago, IL 60661

Retail investors

Erin Sekula, Investor relations

erin.sekula@gehealthcare.com

Attn: Investor relations

GE HealthCare

500 West Monroe Street

Chicago, IL 60661

Transfer agent

Equiniti Trust Company

www.shareowneronline.com

+1-833-914-2122 (toll free)

+1-651-450-4064 (international number)

GE HealthCare Investor Relations

investor@gehealthcare.com

833-735-1139

Stay connected with investor news

ge-icon

Investor Relations

GEHealthcare.com

© 2026 GE HealthCare. GE is a trademark of General Electric Company. Used under trademark license.

California Privacy Policy
Careers
Cookie Preferences
Security
Terms and Conditions
Privacy Policy
Compliance